A5068218701- Pancreatic and Hepatic Oncology Research
- Pancreatitis Pathology and Treatment
- Neuroendocrine Tumor Research Advances
- Breast Cancer Treatment Studies
- Renal cell carcinoma treatment
- Global Cancer Incidence and Screening
- Economic and Financial Impacts of Cancer
- Breast Implant and Reconstruction
- Pain Management and Opioid Use
- Breast Lesions and Carcinomas
- Cancer Genomics and Diagnostics
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gallbladder and Bile Duct Disorders
- Lung Cancer Research Studies
- Anesthesia and Pain Management
- Sarcoma Diagnosis and Treatment
- Neuroblastoma Research and Treatments
- Vascular Malformations and Hemangiomas
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Screening and Detection
- Lung Cancer Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Palliative Care and End-of-Life Issues
The University of Texas MD Anderson Cancer Center
2020-2025
University of Nebraska Medical Center
2017-2024
Burroughs Wellcome Fund
2024
Texas A&M University
2024
Nebraska Medical Center
2017-2024
Yahoo (United Kingdom)
2023
Society for Surgery of the Alimentary Tract
2023
University of Toronto
2016-2022
Holland Bloorview Kids Rehabilitation Hospital
2022
St. Luke's Hospital
2021
Objective: To characterize associations between carbohydrate antigen 19–9 (CA19–9) dynamics during neoadjuvant therapy (NT) and survival for patients with pancreatic ductal adenocarcinoma (PDAC). Background: Although normalization of CA19–9 NT is associated improved outcomes following PDAC resection, we hypothesize that can improve prognostication. Methods: Characteristics undergoing (July 2011–October 2018) ≥3 results (bilirubin<2mg/dL) were collected grouped by dynamics. Nonproducers...
Objective: We aimed to determine if advances in neoadjuvant therapy affected recurrence patterns and survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma (PDAC). Background: Data are limited on how modern multimodality affects PDAC post-recurrence survival. Methods: Patients who received followed by curative-intent during 1998-2018 were identified. Treatments, sites timing, compared between patients completed 1998-2004, 2005-2011, 2012-2018. Results: The study included...
Postoperative opioid overprescribing leads to persistent use and excess pills at risk for misuse diversion. A learning health system paradigm using risk-stratified pancreatectomy clinical pathways (RSPCPs) may lead reduction in inpatient discharge volume.
Breast angiosarcoma (AS) accounts for less than 1% of all breast cancers. The goal this study was to determine patient outcomes in radiation-associated the (RAAS) and sporadic AS. We evaluated patterns recurrence predictors AS survival.Patients with pathologically confirmed from 1994 2014 referred Mount Sinai Hospital/Princess Margaret Cancer Centre were included. Primary outcome overall survival (OS). Secondary disease-free (DFS), clinicopathologic characteristics, factors predictive...
Abstract Background/Purpose Risk‐stratified pancreatectomy clinical pathways using regional anesthesia and multimodality analgesia have decreased overall opioid use, but the additional benefits of robotic surgery in reduction for pancreatoduodenectomy (PD) are unknown. We compared inpatient use between PD open PD. Methods Patients undergoing within a protocol evaluating preincisional anesthetic block bundles were to consecutively‐treated patients identified from prospectively maintained...
Oncoplastic breast surgery combines traditional oncologic conservation with plastic techniques to achieve improved aesthetic and quality-of-life outcomes without sacrificing safety. Clinical uptake training remain limited in the Canadian surgical system. In present article, we detail current state of oncoplastic (ops) Canada, United States, worldwide, as well experience a clinical fellow ops.The undertook 9-month audit cases. All cases performed during fellow's ops fellowship were included....
Breast-conserving surgery with adjuvant radiation therapy is widely accepted as a universal standard of care for women early-stage breast cancer. Oncoplastic breast-conserving (OPS) techniques have emerged in recent years, facilitating the achievement better cosmetic results while adhering to good oncological principles. Compared rest international community, Canada has been fairly slow its clinical uptake OPS. This commentary discusses how can increase capacity
<h3>Background:</h3> Oncoplastic surgery (OPS) is becoming the new standard of care for breast-conserving (BCS). It has become increasingly popular in Europe; however, it not yet been widely accepted North America. This study aims to describe experience with OPS at a Canadian tertiary centre. <h3>Methods:</h3> retrospective case series consisting consecutive cases single centre, Royal Victoria Regional Health Centre Barrie, Ontario, between 2009 and 2015. <h3>Results:</h3> A total 275 women...
A young woman in her 20s was found to have a left breast malignant phyllodes tumour by ultrasound-guided core needle biopsy, after identifying palpable lump. She then underwent lumpectomy excision with >1 cm gross margins; however, final pathology demonstrated <1 margins at the superior margin. re-excision of and medial ensure least 1 Biopsy tract not excised initial or surgery. Approximately 6 weeks completion lumpectomy, patient noted new mass near previous biopsy site punch biopsy. Final...
Racial disparities of surgical outcomes have been demonstrated for a variety operations. We sought to determine whether minority status is associated with disparate care adrenalectomy.This study retrospective database review the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) from January 1, 2014 through April 30, 2018. Primary outcome was complication rate. Secondary were length stay and surgeon experience. Minority defined as Black or Hispanic compared White...
~~~~~~~~~~~~~~~~~~~~~~L MEIrICAL JOURNA&L formalinization is increased, the toxicity reduced, but, unfortunately, so also immunizing efficiency.Veldee has studied method extensively during past few years.He inclines to view that must not be carried too far; unless approximately 500 skin test doses of toxin per cubic centimetre are left, high immunity secured, even with three and addition alum.Here again it pointed out experience indicates progress would more rapid in England if opportunities...
Abstract Background Normal(ization) of serum carbohydrate 19‐9 (CA19‐9) before/after surgery has not been compared in patients with pancreatic adenocarcinoma (PDAC) treated neoadjuvant therapy (NT) versus surgery‐first (SF). Methods Characteristics for PDAC who underwent resection from July 2011 to October 2018 were collected. Patients pre‐/postoperative CA19‐9, bilirubin <2 mg/dL, and initial CA19‐9 > 1 U/ml included. Overall survival (OS) recurrence‐free (RFS) by CA19‐9. Results In...
Objective: This study’s aim was to compare infectious complications in pancreatoduodenectomy (PD) patients with biliary stents treated short, medium, or long durations of prophylactic antibiotics. Summary/Background Data: Pre-existing have historically been associated higher infection risk after PD. Patients are administered antibiotics, but the optimal duration remains unknown. Methods: single-institution retrospective cohort study included consecutive PD from October 2016 April 2022....